Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4AA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114634957B reveals enzymatic synthesis for 4AA. Offers cost reduction and supply chain reliability for API manufacturing partners.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Novel synthetic method for penem antibiotic intermediate 4AA using L-threonine. High purity 99.34%, scalable process, cost-effective manufacturing solution.